Drug makers charge high prices for drugs thanks largely to “market exclusivity” regulations intended to allow them to recoup the research and development costs for new breakthrough medications, said senior author Ameet Sarpatwari. He’s an instructor at Harvard Medical School and the Harvard T.H...
Rise in Drug Prices Well Outpaces Overall Inflation.Reports on the increase in prescription-drug prices in the U.S. which are growing faster than the country's overall inflation rate.LueckSarahEBSCO_bspWall Street Journal Eastern Edition
Meanwhile, your prescription drug insurer may push you to go to a certain pharmacy, chain store or mail order service to fill your prescription because they have negotiated lower prices overall with a certain vendor. That makes sense. But again, it may not be the best deal when you consider...
Thenational debateover exorbitant prescription drugprices—and how to relieve them—was supposed to take center stage in recent weeks, as House Speaker Nancy Pelosi released a plan to negotiate prices for as many as 250 name-brand drugs, including high-priced insulin, for Medicare beneficiaries. A...
Projections show that in 2015 prescription drug spending is expected to slow, as payers and the drug industry negotiate prices, authors wrote. The report, however, did not include Praluent, the recently approved injection drug to treat high cholesterol, which puts people at risk for...
The road to competitive generic drug prices in Canada The price of generic drugs has generated much debate over the past several years. The latest development came at a meeting of all Canadian premiers, who ca... MR Law,J Kratzer - 《Canadian Medical Association Journal Journal De Lassociation...
The prescription drug market is not a free market in that medical necessity, rather than demand and consumer choice, drive prices. There is also a tremendous barrier to entry in that new drug products must meet be approved by FDA and are then given a prolonged period of market exclus...
In 2024, prescription drug spending remained the fastest-growing cost for employers, rising 7.2 percent from 8.6 percent in 2023. Among employer concerns are expensive gene and cellular therapies, Umland said. Such therapies can cost $1 million or more. “These drugs are at cost levels that ...
Present changes to Australian drug pricing arrangements (see the editorial accompanying this article) are driven by concerns that the Pharmaceutical Benefits Scheme (PBS) provides for unnecessarily high prices for generic products. This contention is confirmed in the following analysis, which explores the...
Slowly: Curing the Epidemic Rise of Cancer Drug Prices In August 2015, more than 110 U.S. oncologists published an article detailing the deleterious effects of rising cancer drugs prices and calling for numerous reforms to our prescription drug system. These prices are the result of decades .....